Previous close | 133.95 |
Open | 133.95 |
Bid | 133.95 x 100000 |
Ask | 134.15 x 100000 |
Day's range | 133.20 - 134.50 |
52-week range | 82.60 - 135.20 |
Volume | |
Avg. volume | 78 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Does Xylem (XYL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Xylem Inc. (XYL) continued its streak of surpassing revenue expectations.
Xylem (XYL) benefits from strength in the M&CS segment and the acquisition of Evoqua. Its measures to reward its shareholders are encouraging.